nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.0541	0.279	CbGpPWpGaD
Bimatoprost—Urine abnormality—Omeprazole—Barrett's esophagus	0.025	0.0332	CcSEcCtD
Bimatoprost—Urine abnormality—Esomeprazole—Barrett's esophagus	0.025	0.0332	CcSEcCtD
Bimatoprost—Urine analysis abnormal—Omeprazole—Barrett's esophagus	0.0235	0.0313	CcSEcCtD
Bimatoprost—Urine analysis abnormal—Esomeprazole—Barrett's esophagus	0.0235	0.0313	CcSEcCtD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.0195	0.101	CbGpPWpGaD
Bimatoprost—Scotoma—Esomeprazole—Barrett's esophagus	0.0182	0.0242	CcSEcCtD
Bimatoprost—Scotoma—Omeprazole—Barrett's esophagus	0.0182	0.0242	CcSEcCtD
Bimatoprost—Eye irritation—Omeprazole—Barrett's esophagus	0.0162	0.0215	CcSEcCtD
Bimatoprost—Eye irritation—Esomeprazole—Barrett's esophagus	0.0162	0.0215	CcSEcCtD
Bimatoprost—PTGER3—smooth muscle tissue—Barrett's esophagus	0.0135	0.309	CbGeAlD
Bimatoprost—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.0135	0.018	CcSEcCtD
Bimatoprost—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.0135	0.018	CcSEcCtD
Bimatoprost—Cystitis—Esomeprazole—Barrett's esophagus	0.0133	0.0177	CcSEcCtD
Bimatoprost—Cystitis—Omeprazole—Barrett's esophagus	0.0133	0.0177	CcSEcCtD
Bimatoprost—Dry eye—Omeprazole—Barrett's esophagus	0.0128	0.017	CcSEcCtD
Bimatoprost—Dry eye—Esomeprazole—Barrett's esophagus	0.0128	0.017	CcSEcCtD
Bimatoprost—Bladder pain—Esomeprazole—Barrett's esophagus	0.0125	0.0166	CcSEcCtD
Bimatoprost—Bladder pain—Omeprazole—Barrett's esophagus	0.0125	0.0166	CcSEcCtD
Bimatoprost—PTGFR—smooth muscle tissue—Barrett's esophagus	0.0108	0.247	CbGeAlD
Bimatoprost—PTGER3—digestive system—Barrett's esophagus	0.0107	0.244	CbGeAlD
Bimatoprost—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Barrett's esophagus	0.0106	0.0548	CbGpPWpGaD
Bimatoprost—Visual disturbance—Omeprazole—Barrett's esophagus	0.0106	0.0141	CcSEcCtD
Bimatoprost—Visual disturbance—Esomeprazole—Barrett's esophagus	0.0106	0.0141	CcSEcCtD
Bimatoprost—Tafluprost—PTGS2—Barrett's esophagus	0.0105	1	CrCbGaD
Bimatoprost—Arthritis—Omeprazole—Barrett's esophagus	0.0103	0.0137	CcSEcCtD
Bimatoprost—Arthritis—Esomeprazole—Barrett's esophagus	0.0103	0.0137	CcSEcCtD
Bimatoprost—Diplopia—Omeprazole—Barrett's esophagus	0.01	0.0133	CcSEcCtD
Bimatoprost—Diplopia—Esomeprazole—Barrett's esophagus	0.01	0.0133	CcSEcCtD
Bimatoprost—Dry skin—Esomeprazole—Barrett's esophagus	0.0092	0.0122	CcSEcCtD
Bimatoprost—Dry skin—Omeprazole—Barrett's esophagus	0.0092	0.0122	CcSEcCtD
Bimatoprost—AKR1C3—smooth muscle tissue—Barrett's esophagus	0.00879	0.201	CbGeAlD
Bimatoprost—Asthma—Omeprazole—Barrett's esophagus	0.00867	0.0115	CcSEcCtD
Bimatoprost—Asthma—Esomeprazole—Barrett's esophagus	0.00867	0.0115	CcSEcCtD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.00816	0.0422	CbGpPWpGaD
Bimatoprost—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00806	0.0107	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00806	0.0107	CcSEcCtD
Bimatoprost—Depression—Omeprazole—Barrett's esophagus	0.00771	0.0103	CcSEcCtD
Bimatoprost—Depression—Esomeprazole—Barrett's esophagus	0.00771	0.0103	CcSEcCtD
Bimatoprost—Sinusitis—Omeprazole—Barrett's esophagus	0.00725	0.00964	CcSEcCtD
Bimatoprost—Sinusitis—Esomeprazole—Barrett's esophagus	0.00725	0.00964	CcSEcCtD
Bimatoprost—Rhinitis—Esomeprazole—Barrett's esophagus	0.00696	0.00925	CcSEcCtD
Bimatoprost—Rhinitis—Omeprazole—Barrett's esophagus	0.00696	0.00925	CcSEcCtD
Bimatoprost—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00689	0.00916	CcSEcCtD
Bimatoprost—Pharyngitis—Omeprazole—Barrett's esophagus	0.00689	0.00916	CcSEcCtD
Bimatoprost—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00684	0.00909	CcSEcCtD
Bimatoprost—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00684	0.00909	CcSEcCtD
Bimatoprost—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00682	0.00907	CcSEcCtD
Bimatoprost—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00682	0.00907	CcSEcCtD
Bimatoprost—Visual impairment—Omeprazole—Barrett's esophagus	0.00669	0.00889	CcSEcCtD
Bimatoprost—Visual impairment—Esomeprazole—Barrett's esophagus	0.00669	0.00889	CcSEcCtD
Bimatoprost—Eye disorder—Esomeprazole—Barrett's esophagus	0.00649	0.00862	CcSEcCtD
Bimatoprost—Eye disorder—Omeprazole—Barrett's esophagus	0.00649	0.00862	CcSEcCtD
Bimatoprost—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00626	0.00832	CcSEcCtD
Bimatoprost—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00626	0.00832	CcSEcCtD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.0061	0.0315	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.00598	0.0309	CbGpPWpGaD
Bimatoprost—Tension—Omeprazole—Barrett's esophagus	0.00593	0.00788	CcSEcCtD
Bimatoprost—Tension—Esomeprazole—Barrett's esophagus	0.00593	0.00788	CcSEcCtD
Bimatoprost—Nervousness—Omeprazole—Barrett's esophagus	0.00587	0.0078	CcSEcCtD
Bimatoprost—Nervousness—Esomeprazole—Barrett's esophagus	0.00587	0.0078	CcSEcCtD
Bimatoprost—Vision blurred—Omeprazole—Barrett's esophagus	0.00569	0.00757	CcSEcCtD
Bimatoprost—Vision blurred—Esomeprazole—Barrett's esophagus	0.00569	0.00757	CcSEcCtD
Bimatoprost—AKR1C3—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00543	0.0281	CbGpPWpGaD
Bimatoprost—Vertigo—Omeprazole—Barrett's esophagus	0.00543	0.00722	CcSEcCtD
Bimatoprost—Vertigo—Esomeprazole—Barrett's esophagus	0.00543	0.00722	CcSEcCtD
Bimatoprost—Palpitations—Omeprazole—Barrett's esophagus	0.00534	0.0071	CcSEcCtD
Bimatoprost—Palpitations—Esomeprazole—Barrett's esophagus	0.00534	0.0071	CcSEcCtD
Bimatoprost—Cough—Esomeprazole—Barrett's esophagus	0.00527	0.00701	CcSEcCtD
Bimatoprost—Cough—Omeprazole—Barrett's esophagus	0.00527	0.00701	CcSEcCtD
Bimatoprost—Hypertension—Esomeprazole—Barrett's esophagus	0.00522	0.00694	CcSEcCtD
Bimatoprost—Hypertension—Omeprazole—Barrett's esophagus	0.00522	0.00694	CcSEcCtD
Bimatoprost—Chest pain—Esomeprazole—Barrett's esophagus	0.00514	0.00684	CcSEcCtD
Bimatoprost—Chest pain—Omeprazole—Barrett's esophagus	0.00514	0.00684	CcSEcCtD
Bimatoprost—PTGFR—G alpha (q) signalling events—GAST—Barrett's esophagus	0.00513	0.0265	CbGpPWpGaD
Bimatoprost—Anxiety—Esomeprazole—Barrett's esophagus	0.00513	0.00682	CcSEcCtD
Bimatoprost—Anxiety—Omeprazole—Barrett's esophagus	0.00513	0.00682	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00511	0.00679	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00511	0.00679	CcSEcCtD
Bimatoprost—Dry mouth—Esomeprazole—Barrett's esophagus	0.00503	0.00669	CcSEcCtD
Bimatoprost—Dry mouth—Omeprazole—Barrett's esophagus	0.00503	0.00669	CcSEcCtD
Bimatoprost—PTGER1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.00502	0.0259	CbGpPWpGaD
Bimatoprost—Infection—Esomeprazole—Barrett's esophagus	0.0049	0.00651	CcSEcCtD
Bimatoprost—Infection—Omeprazole—Barrett's esophagus	0.0049	0.00651	CcSEcCtD
Bimatoprost—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00484	0.00643	CcSEcCtD
Bimatoprost—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00484	0.00643	CcSEcCtD
Bimatoprost—Skin disorder—Omeprazole—Barrett's esophagus	0.00479	0.00637	CcSEcCtD
Bimatoprost—Skin disorder—Esomeprazole—Barrett's esophagus	0.00479	0.00637	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00459	0.0237	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00449	0.0232	CbGpPWpGaD
Bimatoprost—Insomnia—Esomeprazole—Barrett's esophagus	0.00446	0.00593	CcSEcCtD
Bimatoprost—Insomnia—Omeprazole—Barrett's esophagus	0.00446	0.00593	CcSEcCtD
Bimatoprost—Dyspnoea—Esomeprazole—Barrett's esophagus	0.0044	0.00585	CcSEcCtD
Bimatoprost—Dyspnoea—Omeprazole—Barrett's esophagus	0.0044	0.00585	CcSEcCtD
Bimatoprost—Somnolence—Omeprazole—Barrett's esophagus	0.00438	0.00583	CcSEcCtD
Bimatoprost—Somnolence—Esomeprazole—Barrett's esophagus	0.00438	0.00583	CcSEcCtD
Bimatoprost—Dyspepsia—Omeprazole—Barrett's esophagus	0.00434	0.00577	CcSEcCtD
Bimatoprost—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00434	0.00577	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00426	0.00566	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00426	0.00566	CcSEcCtD
Bimatoprost—Pain—Esomeprazole—Barrett's esophagus	0.00422	0.00561	CcSEcCtD
Bimatoprost—Pain—Omeprazole—Barrett's esophagus	0.00422	0.00561	CcSEcCtD
Bimatoprost—PTGER3—G alpha (i) signalling events—SST—Barrett's esophagus	0.00392	0.0202	CbGpPWpGaD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00383	0.0198	CbGpPWpGaD
Bimatoprost—Asthenia—Omeprazole—Barrett's esophagus	0.00354	0.0047	CcSEcCtD
Bimatoprost—Asthenia—Esomeprazole—Barrett's esophagus	0.00354	0.0047	CcSEcCtD
Bimatoprost—Pruritus—Omeprazole—Barrett's esophagus	0.00349	0.00464	CcSEcCtD
Bimatoprost—Pruritus—Esomeprazole—Barrett's esophagus	0.00349	0.00464	CcSEcCtD
Bimatoprost—Dizziness—Omeprazole—Barrett's esophagus	0.00326	0.00434	CcSEcCtD
Bimatoprost—Dizziness—Esomeprazole—Barrett's esophagus	0.00326	0.00434	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00311	0.0161	CbGpPWpGaD
Bimatoprost—Rash—Omeprazole—Barrett's esophagus	0.00311	0.00413	CcSEcCtD
Bimatoprost—Rash—Esomeprazole—Barrett's esophagus	0.00311	0.00413	CcSEcCtD
Bimatoprost—Dermatitis—Omeprazole—Barrett's esophagus	0.00311	0.00413	CcSEcCtD
Bimatoprost—Dermatitis—Esomeprazole—Barrett's esophagus	0.00311	0.00413	CcSEcCtD
Bimatoprost—Headache—Omeprazole—Barrett's esophagus	0.00309	0.00411	CcSEcCtD
Bimatoprost—Headache—Esomeprazole—Barrett's esophagus	0.00309	0.00411	CcSEcCtD
Bimatoprost—Nausea—Omeprazole—Barrett's esophagus	0.00293	0.00389	CcSEcCtD
Bimatoprost—Nausea—Esomeprazole—Barrett's esophagus	0.00293	0.00389	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00279	0.0144	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—SST—Barrett's esophagus	0.00237	0.0123	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00233	0.012	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00228	0.0118	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—GAST—Barrett's esophagus	0.00195	0.0101	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—GAST—Barrett's esophagus	0.00178	0.00917	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—SST—Barrett's esophagus	0.00177	0.00916	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—SST—Barrett's esophagus	0.00174	0.00897	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.00153	0.00788	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—GAST—Barrett's esophagus	0.00146	0.00755	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—GAST—Barrett's esophagus	0.00143	0.00739	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—SST—Barrett's esophagus	0.00134	0.00692	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GAST—Barrett's esophagus	0.00133	0.00686	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—GAST—Barrett's esophagus	0.0013	0.00672	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGES—Barrett's esophagus	0.00124	0.00642	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—SST—Barrett's esophagus	0.00122	0.00629	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.00121	0.00627	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GAST—Barrett's esophagus	0.00105	0.00542	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—SST—Barrett's esophagus	0.001	0.00518	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—SST—Barrett's esophagus	0.000981	0.00507	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP26A1—Barrett's esophagus	0.000942	0.00487	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000924	0.00477	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—SST—Barrett's esophagus	0.00091	0.0047	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000907	0.00469	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—SST—Barrett's esophagus	0.000891	0.0046	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000888	0.00459	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SLC9A1—Barrett's esophagus	0.000811	0.00419	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GAST—Barrett's esophagus	0.000784	0.00405	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GAST—Barrett's esophagus	0.000768	0.00397	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GAST—Barrett's esophagus	0.000741	0.00383	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SST—Barrett's esophagus	0.000719	0.00371	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000696	0.0036	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000691	0.00357	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SLC9A1—Barrett's esophagus	0.000679	0.00351	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000676	0.00349	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000548	0.00283	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SST—Barrett's esophagus	0.000537	0.00278	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SST—Barrett's esophagus	0.000526	0.00272	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000522	0.0027	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SST—Barrett's esophagus	0.000508	0.00262	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000474	0.00245	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.00039	0.00202	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APC—Barrett's esophagus	0.000383	0.00198	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000382	0.00197	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APC—Barrett's esophagus	0.00038	0.00197	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000354	0.00183	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000347	0.00179	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARG—Barrett's esophagus	0.00031	0.0016	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RELA—Barrett's esophagus	0.000297	0.00154	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—Barrett's esophagus	0.000291	0.0015	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APC—Barrett's esophagus	0.000284	0.00147	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—Barrett's esophagus	0.00028	0.00145	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APC—Barrett's esophagus	0.000278	0.00144	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APC—Barrett's esophagus	0.000269	0.00139	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—Barrett's esophagus	0.000244	0.00126	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RELA—Barrett's esophagus	0.000222	0.00115	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RELA—Barrett's esophagus	0.000217	0.00112	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RELA—Barrett's esophagus	0.00021	0.00108	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—Barrett's esophagus	0.000209	0.00108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—Barrett's esophagus	0.000205	0.00106	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—Barrett's esophagus	0.000198	0.00102	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—Barrett's esophagus	0.000172	0.000888	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—Barrett's esophagus	0.000129	0.000664	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—Barrett's esophagus	0.000126	0.00065	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—Barrett's esophagus	0.000121	0.000627	CbGpPWpGaD
